Lv11
26 积分 2024-09-06 加入
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
6分钟前
待确认
Advances in the classification and management of idiopathic inflammatory myopathies
2天前
已完结
Idiopathic inflammatory myopathies: current insights and future frontiers
2天前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
18天前
已完结
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report
25天前
已完结
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
25天前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
26天前
已完结
Application of BCMA CAR-T in systemic lupus erythematosus
26天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
27天前
已完结
Rapid CAR-T manufacturing with low-intensity priming enhances CAR-T cell fitness and limits inflammatory programming in a phase 1 study
1个月前
已完结
皖公网安备34019202002308
